盐酸帕罗西汀与氟西汀治疗躯体形式障碍的疗效及安全性比较
2018-02-06姚艳苓
姚艳苓
【摘要】目的 比较盐酸帕罗西汀与氟西汀治疗躯体形式障碍的临床治疗效果与安全性。方法 选择2016年2月~2017年2月于我院就诊的躯体形式障碍的患者,共100例,按照入院编号随机分为两组,每组50例。对照组给予氟西汀治疗,观察组采用盐酸帕罗西汀治疗,对两组患者的临床疗效和不良反应进行科学的比较。结果 治疗前,两组患者的HAMD评分差异不显著,无统计学意义(P>0.05);经过治疗两组患者的HAMD评分均有所降低 ,但是观察组的降低幅度明显大于对照组,差异有统计学意义(P<0.05);两组患者在治疗期间,TESS评分不断下降,各时段差异不明显,无统计学意义(P>0.05);观察组的总有效率明显比对照组高,差异有统计学意义(P<0.05)。结论 在治疗躯体形式障碍时,应用盐酸帕罗西汀治疗有助于增强治疗效果,减少不良反应,值得临床应用与推广。
【关键词】盐酸帕罗西汀;氟西汀;躯体形式障碍;疗效;安全性
【中图分类号】R749.2 【文献标识码】A 【文章编号】ISSN.2095-6681.2017.25..02
【Abstract】Objective To compare the clinical efficacy and safety of Pa Rossi Dean hydrochloride and fluoxetine in the treatment of somatoform disorders.Methods somatoform disorders in February 2016~2017 year in February in our hospital patients, a total of 100 cases,according to the admission number were randomly divided into two groups,50 cases in each group. The control group was given fluoxetine treatment,observation group the Pa Rossi Dean hydrochloride treatment,scientific comparison of curative effect and adverse reaction of two groups of patients.Results Before treatment,HAMD score between the two groups was not significant, no statistical significance (P>0.05);after the treatment,two groups of patients in HAMD.Points were lower, but the observation group decreased more than the control group,the difference was statistically significant (P<0.05);the two groups of patients during treatment, TESS score decreased, the time difference is not obvious, no statistical significance(P>0.05);the total effective rate of observation group was significantly higher than the control group, the difference was statistically significant (P<0.05).Conclusion In the treatment of somatoform disorder, application of Pa Rossi Dean therapy is helpful to improve the curative effect,reduce adverse reactions, worthy of clinical application and promotion.
【Key words】Paroxetine hydrochloride;Fluoxetine;Somatoform disorder;Curative effect Safety
本次研究的主要目的是比较盐酸帕罗西汀与氟西汀治疗躯体形式障碍的临床治疗效果与安全性,选取了2016年2月~2017年2月于我院就诊的100例躯体形式障碍的患者,以其作为分析对象,其中观察组应用盐酸帕罗西汀治疗,在临床上取得的疗效十分良好,具体情况介绍如下。
1 资料与方法
1.1 一般资料
本次研究的主要对象,选取的是我院于2016年2月~2017年2月接受治疗的100例躯体形式障碍患者,男58例、女42例,与临床诊断标准相符,病程在3个月及其以上。现根据入院编号将其随机分为两组,每组各有患者50例,观察组年龄年龄18~72岁,平均年龄(50.6±2.9)岁;对照组年龄17~71岁,平均年龄(48.9±3.6)岁。经比对,患者的临床资料无统计学意义(P>0.05),有可比性。
1.2 方法
對照组进行氟西汀治疗,采用口服的形式,初始剂量每天给予20 mg,以后按照病情变化可逐渐增加至每天40 mg。……p>
